Goldman Sachs analysts published today a new investment list that consists of 22 stocks highlighted by the broker's research analysts. It includes fundamental Buy-rated U.S. stocks chosen by Goldman's "Investment Review Committee."
"This new "Conviction List – Directors' Cut" is designed to provide investors with a curated and active list of 20-25 of what we believe to be our most differentiated fundamental Buy ideas across our US stock coverage," Kron said in a client note.
The list includes mega-cap names like Apple (NASDAQ:AAPL) and Amazon (NASDAQ:AMZN). These two tech stocks offer 18% and 37% upside, respectively, based on Goldman Sachs' price targets.
Other stocks included in the list with a market capitalization exceeding $50 billion include Salesforce (NYSE:CRM), Vertex Pharma (NASDAQ:VRTX), Merck (NYSE:MRK), HCA Healthcare (NYSE:HCA), and JPMorgan Chase (NYSE:JPM).
Stocks with the highest potential are WW International (NASDAQ:WW) and Warner Bros Discovery (NASDAQ:WBD) as analysts see 98% and 86% upside, respectively.